A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders
Recruiting now · Not applicable
Conditions studied: Cognitive Disorder
In brief
The study aims to test a program combining cognitive behavioral therapy techniques, positive psychology techniques, mindfulness meditation and yoga, in order to improve resilience in patient with minor cognitive disorder. This intervention will be compared to a control group, but also with a group testing another intervention (an intervention that does not improve resilience in the elderly, namely a "cognitive stimulation" intervention) in order to ensure that the effect potentially obtained is not due to the simple management of the participant. The duration of the intervention will be 3 months, with an evaluation directly before and after the intervention. In addition, in order to best evaluate the effectiveness of the interventions over time, two follow-up measurements will be proposed: a measurement one month after the intervention, then a final one three months after the intervention.
Key facts
- Study ID
- NCT06801171
- Run by
- Centre Hospitalier Universitaire de Nice
- People needed
- 90
- Starts
- 2025-04-30
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2025-05-04
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Man or Woman aged > 60 years
- Have a minor neurocognitive disorder according to the criteria of the DSM 5
- Score of 145 or less on the Wagnild and Young Resilience Scale (RS) (Wagnild, 2009).
- Subject able to read and write French;
- Subject beneficiaries of a social security scheme;
- Ability to understand and sign free and informed consent.
You may not qualify if…
- Subject already practicing meditation and/or yoga and/or Tai Chi
- Subject currently undergoing psychological therapy (whatever the approach)
- Subject with a major hearing, visual or motor disability likely to interfere with the proposed interventions or the performance of assessments;
- Presence and/or recent history (within the last 5 years prior to inclusion in the study) of major psychiatric disorders (e.g., schizophrenia, severe depression, addiction, bipolar disorders, psychotic disorders, risk of dissociation, panic attack, generalized anxiety disorder, etc.)
- If taking psychotropic treatment, the dose must have been stable for 4 weeks
- Vulnerable persons are defined in Articles L1121-5 to -8
Where it is running
- CHU de Nice — Nice, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.